Finzati - Logo
KNSA logo

Kiniksa Pharmaceuticals International, plc

KNSA • Medical - Pharmaceuticals
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$6.17B
Growth
—
Cash Flow
4/5
Trend
Mostly stable
Evidence
Positive revenue growth · 100.8%Positive free cash flow · 0.34Consistent free cash flow · 4/5Manageable debt level · 0.02Healthy liquidity · 3.79
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$6.17B
52W Range29.90 - 82.94
Beta0.07
Gross Margin54.63%
Oper. Margin11.40%
Profit Margin8.71%
Debt/Eq0.02
Current Ratio3.79
Quick Ratio3.39
Target$86.40

Investment DNA

How strong this company looks for long-term investors

67
out of 100
Business Quality
Margins, moat, returns
64/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
37/100
Why this score▼
Positive revenue growth · 100.8%Positive free cash flow · 0.34Consistent free cash flow · 4/5Manageable debt level · 0.02Healthy liquidity · 3.79Expensive earnings multiple · 51.56

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-07-30
Low
$71.00
Mean
$86.40
Median
$90.00
High
$99.00

Company Overview

IPO: 5/24/2018
Industry: Medical - Pharmaceuticals
P/B i: 5.39
Debt / Equity i: 0.02
Operating Margin: 11.40%
Net Margin: 8.71%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.02
Current Ratio: 3.79
Quick Ratio: 3.39
Status: Good

Insider Transactions

Recent executive and insider activity

⚠ 1 high-volume insider sell detected
Malkani Dhiraj H
Transaction: 07/01/2026
BUY
Change
+1,307
Price
Not reported
Filing
07/06/2026
Type
BUY
Malkani Dhiraj H
Transaction: 07/01/2026
BUY
Change
+2,188
Price
$62.88
Filing
07/06/2026
Type
BUY
Malkani Dhiraj H
Transaction: 07/01/2026
BUY
Change
+14,000
Price
Not reported
Filing
07/06/2026
Type
BUY